Danny Joh

1.4k total citations
10 papers, 1.2k citations indexed

About

Danny Joh is a scholar working on Molecular Biology, Infectious Diseases and Immunology and Allergy. According to data from OpenAlex, Danny Joh has authored 10 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Infectious Diseases and 4 papers in Immunology and Allergy. Recurrent topics in Danny Joh's work include Biochemical and Structural Characterization (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Cell Adhesion Molecules Research (4 papers). Danny Joh is often cited by papers focused on Biochemical and Structural Characterization (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Cell Adhesion Molecules Research (4 papers). Danny Joh collaborates with scholars based in United States, Italy and Sweden. Danny Joh's co-authors include Magnus Höök, Pietro Speziale, Elisabeth R. Wann, Kevin P. Francis, Pamela R. Contag, Tony Purchio, Bernd Kreikemeyer, Staffan Johansson, Timothy J. Foster and Michael G. Caparon and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Infection and Immunity.

In The Last Decade

Danny Joh

10 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danny Joh United States 9 629 436 222 187 155 10 1.2k
Simonetta Rindi Italy 21 564 0.9× 448 1.0× 258 1.2× 54 0.3× 178 1.1× 45 1.2k
Gunnar Fröman Sweden 16 417 0.7× 270 0.6× 162 0.7× 32 0.2× 125 0.8× 36 972
Giuseppe Raucci Italy 11 502 0.8× 450 1.0× 301 1.4× 22 0.1× 121 0.8× 19 939
Peter Sillekens Netherlands 27 819 1.3× 333 0.8× 120 0.5× 262 1.4× 695 4.5× 44 2.0k
Andrew Levin United States 16 373 0.6× 376 0.9× 444 2.0× 38 0.2× 92 0.6× 35 1.6k
S. Roels Belgium 18 325 0.5× 263 0.6× 120 0.5× 64 0.3× 207 1.3× 95 1.1k
Gustavo Cabral‐Miranda United Kingdom 16 393 0.6× 370 0.8× 171 0.8× 122 0.7× 197 1.3× 34 1.1k
Sławomir Łukomski United States 29 536 0.9× 1.1k 2.5× 1.4k 6.4× 100 0.5× 438 2.8× 59 2.4k
Lars Frykberg Sweden 24 807 1.3× 585 1.3× 459 2.1× 24 0.1× 165 1.1× 40 1.6k
Tara J. Moriarty Canada 19 418 0.7× 358 0.8× 111 0.5× 34 0.2× 135 0.9× 29 1.3k

Countries citing papers authored by Danny Joh

Since Specialization
Citations

This map shows the geographic impact of Danny Joh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny Joh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny Joh more than expected).

Fields of papers citing papers by Danny Joh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny Joh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny Joh. The network helps show where Danny Joh may publish in the future.

Co-authorship network of co-authors of Danny Joh

This figure shows the co-authorship network connecting the top 25 collaborators of Danny Joh. A scholar is included among the top collaborators of Danny Joh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny Joh. Danny Joh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Park, Chaeun, Young Woo Kang, Danny Joh, et al.. (2022). Abstract 2608: Pre-clinical evaluation of small molecule CHK2 inhibitor, ART-122 combined with olaparib in BRCA wild type tumors. Cancer Research. 82(12_Supplement). 2608–2608. 1 indexed citations
3.
Francis, Kevin P., Jun Yu, Danny Joh, et al.. (2001). Visualizing Pneumococcal Infections in the Lungs of Live Mice Using Bioluminescent Streptococcus pneumoniae Transformed with a Novel Gram-Positive lux Transposon. Infection and Immunity. 69(5). 3350–3358. 215 indexed citations
4.
Wann, Elisabeth R., et al.. (2000). Cellular invasion by Staphylococcus aureus involves a fibronectin bridge between the bacterial fibronectin-binding MSCRAMMs and host cell β1 integrins. European Journal of Cell Biology. 79(10). 672–679. 217 indexed citations
5.
Francis, Kevin P., et al.. (2000). Monitoring BioluminescentStaphylococcus aureusInfections in Living Mice Using a NovelluxABCDEConstruct. Infection and Immunity. 68(6). 3594–3600. 278 indexed citations
6.
Joh, Danny, Elisabeth R. Wann, Bernd Kreikemeyer, Pietro Speziale, & Magnus Höök. (1999). Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biology. 18(3). 211–223. 216 indexed citations
7.
Joh, Danny, et al.. (1998). Multiple specificities of the staphylococcal and streptococcal fibronectin‐binding microbial surface components recognizing adhesive matrix molecules. European Journal of Biochemistry. 258(2). 897–905. 54 indexed citations
8.
Visai, Livia, Danny Joh, Pier Giulio Conaldi, et al.. (1998). Antibody Response to Fibronectin-Binding Adhesin FnbpA in Patients with Staphylococcus aureus Infections. Infection and Immunity. 66(11). 5433–5442. 48 indexed citations
9.
Speziale, Pietro, et al.. (1996). A Monoclonal Antibody Enhances Ligand Binding of Fibronectin MSCRAMM (Adhesin) from Streptococcus dysgalactiae. Journal of Biological Chemistry. 271(3). 1371–1378. 35 indexed citations
10.
Xu, Yun, et al.. (1996). Conformational Changes in the Fibronectin Binding MSCRAMMs Are Induced by Ligand Binding. Journal of Biological Chemistry. 271(3). 1379–1384. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026